6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Kuchena >98.0% (LCMS) Ensitrelvir (S-217622) Intermediate COVID-19 Featured Image

6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Kuchena >98.0% (LCMS) Ensitrelvir (S-217622) Yepakati COVID-19

Tsanangudzo Pfupi

Zita: 6-Chloro-2-methyl-2H-indazol-5-amine

CAS: 1893125-36-4

Kuchena:> 98.0% (LCMS)

Chitarisiko: Chiedza Chitsvuku kusvika kuGrey Solid Powder

Pakati peEnsitrelvir (S-217622), COVID-19

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Commercial Supply Ensitrelvir (S-217622) Pakati:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl) -1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8

Chemical Properties:

Chemical Name	6-Chloro-2-methyl-2H-indazol-5-amine
Nhamba yeCAS	1893125-36-4
Nhamba yeCAT	RF-PI1506
Stock Status	Mudura
Molecular Formula	C8H8ClN3
Molecular Weight	181.62
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Chiedza Chitsvuku kusvika kuGrey Solid Powder
Kuchena / Analysis Method	>98.0% (LCMS)
1 H NMR Spectrum	Zvinoenderana Nechimiro
LCMS	Zvinoenderana Nechimiro
Kurasika paKuomesa	≤1.00%
Zvose Zvisina Kuchena	<2.00%
Test Standard	Enterprise Standard
Usage	Pakati peEnsitrelvir (S-217622), COVID-19

Package & Kuchengeta:

Package: Bhodhoro, 25kg / Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.

Zvakanakira:

FAQ:

Application:

6-Chloro-2-methyl-2H-indazol-5-amine (CAS: 1893125-36-4) iri pakati peEnsitrelvir (S-217622).Ensitrelvir naShionogi & Co mushonga unorwisa hutachiona unoshanda zvakanyanya sePfizer's Paxlovid.Oral Xocova (Ensitrelvir), iyo ine nzira imwechete yekuita sePfizer's Paxlovid (Nirmatrelvir+Ritonavir), inosiyana pakuti inongoda kutorwa kamwe chete pazuva, nepo ensitrelvir yekurapa isingaite seyakaderera pane Paxlovid.Sechiyeuchidzo, Nirmatrelvir inopihwa kaviri pazuva, pamwe chete nebooster inomiririrwa neRitonavir.Ensitrelvir yakava piritsi rekutanga remumba rekuJapan kurapa COVID-19, yechitatu kubvumidzwa zviri pamutemo muJapan;muna Kukadzi 2022.